A team of scientists from Johns Hopkins and the biotechnology company Genitope has unlocked the 3-D structure of a receptor that goes awry in 20 percent to 30 percent of breast cancers. A team of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results